A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.

@article{Wong2014ANC,
  title={A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.},
  author={L M Wong and Shabbir M H Alibhai and Greg Trottier and Narhari Timilshina and Theodorus H. van der Kwast and Alexandre R. Zlotta and Nathan L Lawrentschuk and Girish S. Kulkarni and Robert J Hamilton and Sarah Ferrara and David Margel and John Trachtenberg and Michael A. S. Jewett and Ants Toi and Andrew J. Evans and Neil E. Fleshner and Antonio Finelli},
  journal={European urology},
  year={2014},
  volume={66 3},
  pages={406-13}
}
BACKGROUND Many men (21-52%) are reported to have no cancer on the second, also known as the confirmatory, biopsy (B2) for prostate cancer active surveillance (AS). If these men had a reduced risk of pathologic progression, particularly grade related, the intensity of their follow-up could be decreased. OBJECTIVE To investigate if men with no cancer on B2… CONTINUE READING